Table 4.
No (%) resistant to | ||||
---|---|---|---|---|
|
||||
Antimicrobial agent | Escherichia coli (n=6) | Klebsiella spp. (n=33) | Other enterobacteria (n=25)1 | Total (n=64) |
Ampicillin | 4 (66.7) | 23 (69.7) | 16 (64) | 43 (67.2) |
Amoxicillin-clavulanic acid | 3 (50) | 16 (48.5) | 9 (36) | 28 (43.8) |
Ceftriaxone | 1 (16.7) | 10 (30.3) | 10 (40) | 21 (32.8) |
Imipenem | 1 (16.7) | 5 (15.2) | 3 (12) | 9 (14.1) |
Chloramphenicol | 2 (33.3) | 10 (30.3) | 10 (40) | 22 (34.4) |
Amikacin | 1 (16.7) | 4 (12.1) | 1 (64) | 6 (9.4) |
Gentamicin | 2 (33.3) | 5 (15.2) | 2 (8) | 9 (14.1) |
Streptomycin | 2 (33.3) | 6 (18.2) | 9 (36) | 17 (26.6) |
Nalidixic acid | 2 (33.3) | 15 (45.5) | 14 (56) | 31 (48.4) |
Ciprofloxacin | 2 (33.3) | 7 (21.2) | 2 (8) | 11 (17.2) |
Nitrofurantoin | 2 (33.3) | 13 (39.4) | 13 (52) | 28 (43.8) |
Trimethoprin-sulfamethoxazole | 4 (66.7) | 8 (24.2) | 4 (16) | 16 (25) |
MDR2 | 3 (50) | 14 (42.4) | 13 (52) | 30 (46.9) |
Other enterobacteria include nine Hafnia alvei, two Citrobacter spp., two Enterobacter amnigenus, two Enterobacter spp., two Pantoea agglomerans, three Serratia spp. and five Yersinia spp.
MDR: multidrug resistance (resistance to three or more antimicrobial groups).